Editorial: Novel preclinical model, biomarker, treatment and drug delivery to address immune evasion in cancer

Chun-Wai Mai; Zuzana Macek Jilkova; Kamal Dua; Bey-Hing Goh

doi:10.3389/fimmu.2024.1486819

Editorial: Novel preclinical model, biomarker, treatment and drug delivery to address immune evasion in cancer

Front Immunol. 2024 Sep 13:15:1486819. doi: 10.3389/fimmu.2024.1486819. eCollection 2024.

Authors

Chun-Wai Mai¹, Zuzana Macek Jilkova^{2

3}, Kamal Dua^{4

5}, Bey-Hing Goh^{6

7}

Affiliations

¹ Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia.
² Univ. Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institute for Advanced Biosciences, Grenoble, France.
³ Hepato-Gastroenterology and Digestive Oncology, Department, University Hospital Grenoble, Grenoble, France.
⁴ Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia.
⁵ Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia.
⁶ Sunway Biofunctional Molecules Discovery Centre, School of Medical and Life Sciences, Sunway University Malaysia, Bandar Sunway, Selangor Darul Ehsan, Malaysia.
⁷ Biofunctional Molecule Exploratory Research Group, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor Darul Ehsan, Malaysia.

No abstract available

Keywords: biomarker; cancer; cancer immunology; modeling; treatment.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Biomarkers, Tumor
Drug Delivery Systems
Humans
Neoplasms* / drug therapy
Neoplasms* / immunology
Neoplasms* / therapy
Tumor Escape / drug effects

Substances

Biomarkers, Tumor

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The authors would like to express their sincere gratitude to research grants provided by the Malaysia Ministry of Health through the Fundamental Research Grant Scheme (FRGS/1/2023/SKK10/UCSI/02/1), UCSI University Research Excellence & Innovation Grant (REIG-FPS-2023/038) and Sunway University Research Accelerator Grant Scheme (GRTIN-RAG-SBMDC-10-2024).